| Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI (NCT05744518) | Fudan University | 2022-01-03 |
| Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy (NCT05674305) | Fudan University | 2022-01-01 |
| Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy (NCT05772208) | Fudan University | 2022-01-01 |
| Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1016) (NCT05794724) | Fudan University | 2022-01-01 |
| Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014) (NCT05794698) | Fudan University | 2022-01-01 |
| Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1015) (NCT05794711) | Fudan University | 2022-01-01 |
| Prehabilitation During Neoadjuvant Chemoradiotherapy for Rectal Cancer (NCT06542354) | Fudan University | 2021-12-20 |
| Efficacy and Safety of Furmonertinib in EGFR-Mutant, PD-L1+ Patients With Locally Advanced or Metastatic NSCLC (FUTURE) (NCT05255406) | Fudan University | 2021-12-09 |
| A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen (NCT05138159) | Fudan University | 2021-12-01 |
| Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010) (NCT05094882) | Fudan University | 2021-12-01 |
| Value of ctDNA in the Treatment of Multiple Primary Cancers (NCT05164510) | Fudan University | 2021-12-01 |
| Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma (NCT05124431) | Fudan University | 2021-12-01 |
| Fruquintinib in the Treatment of Soft Tissue Sarcoma (NCT05142631) | Fudan University | 2021-11-21 |
| Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma (NCT05265793) | Fudan University | 2021-11-21 |
| The Effect of Intervention With Probiotic K56 on Body Fat Reduction in Obese Subjects (NCT05192811) | Fudan University | 2021-11-18 |
| Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC (NCT04136535) | Fudan University | 2021-11-18 |
| Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort Study (NCT05161585) | Fudan University | 2021-11-01 |
| Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer (NCT05594082) | Fudan University | 2021-11-01 |
| Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC. (NCT05142709) | Fudan University | 2021-10-31 |
| Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from Solid Tumors (NCT05098847) | Fudan University | 2021-10-29 |
| Circulating EV Long RNA Profiles in SCLC (NCT05191849) | Fudan University | 2021-10-25 |
| ARX788 in Breast Cancer With Low Expression of HER2 (NCT05018676) | Fudan University | 2021-10-20 |
| Titration of Intraoperative PEEP in Patients Undergoing Robotic Assisted Laparoscopic Prostatectomy (NCT05155371) | Fudan University | 2021-10-20 |
| Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer (NCT05076695) | Fudan University | 2021-10-15 |
| Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) (NCT04520074) | Fudan University | 2021-10-08 |
| Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011) (NCT05252676) | Fudan University | 2021-10-01 |
| Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer (NCT05161572) | Fudan University | 2021-09-28 |
| Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma (NCT05057845) | Fudan University | 2021-09-26 |
| Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer (NCT05059379) | Fudan University | 2021-09-20 |
| Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab (NCT05346861) | Fudan University | 2021-09-15 |
| The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients (NCT05168527) | Fudan University | 2021-09-03 |
| Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer (NCT05446545) | Fudan University | 2021-09-01 |
| GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced BTC (NCT05019677) | Fudan University | 2021-09-01 |
| Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer (NCT05201430) | Fudan University | 2021-08-27 |
| Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer (NCT05010681) | Fudan University | 2021-08-24 |
| Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma (NCT05010668) | Fudan University | 2021-08-24 |
| Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS) (NCT04383275) | Fudan University | 2021-08-23 |
| The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE) (NCT04948034) | Fudan University | 2021-08-23 |
| Acute and Chronic Pain After Video-assisted Thoracoscopic Surgery for Lung Cancer (NCT05478460) | Fudan University | 2021-08-10 |
| Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis (NCT04912258) | Fudan University | 2021-08-01 |
| Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver Transplant (NCT05063071) | Fudan University | 2021-07-29 |
| Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy (NCT04978012) | Fudan University | 2021-07-25 |
| Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma (NCT04997837) | Fudan University | 2021-07-21 |
| Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer (NCT05371301) | Fudan University | 2021-07-16 |
| ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases (NCT05018702) | Fudan University | 2021-07-14 |
| TACE Combined with Sintilimab Plus Bevacizumab Biosimilar in Patients with Advanced Hepatocellular Carcinoma (TASK-02) (NCT04954794) | Fudan University | 2021-07-14 |
| TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma (NCT04954781) | Fudan University | 2021-07-14 |
| The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD) (NCT04517227) | Fudan University | 2021-07-01 |
| Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D) (NCT04922008) | Fudan University | 2021-07-01 |
| Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer (NCT04790305) | Fudan University | 2021-06-18 |
| Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China (NCT04952103) | Fudan University | 2021-06-18 |
| Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC (NCT04912882) | Fudan University | 2021-06-15 |
| Treatment Response Prediction System of mCRC Patients Based on CTC (NCT04917276) | Fudan University | 2021-06-15 |
| Granisetron Transdermal Patch for Prophylaxis of Delayed CINV (NCT04912271) | Fudan University | 2021-06-10 |
| Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment (NCT04706598) | Fudan University | 2021-06-09 |
| Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm (NCT04927611) | Fudan University | 2021-06-06 |
| CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients (NCT04917289) | Fudan University | 2021-06-01 |
| Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention (NCT04665648) | Fudan University | 2021-06-01 |
| Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study (NCT04913571) | Fudan University | 2021-05-27 |
| Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer (NCT04809025) | Fudan University | 2021-05-24 |
| PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUP (NCT04848597) | Fudan University | 2021-05-13 |
| Prepectoral and Subpectoral Implant-based Breast Reconstruction (NCT04688697) | Fudan University | 2021-05-12 |
| Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer (NCT04518280) | Fudan University | 2021-05-01 |
| Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial (NCT05223582) | Fudan University | 2021-05-01 |
| cTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven Criteria (NCT04842565) | Fudan University | 2021-05-01 |
| Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC (NCT04843943) | Fudan University | 2021-05-01 |
| Methylene Blue and Postoperative Neurocognitive Disorders (NCT04529265) | Fudan University | 2021-05-01 |
| FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases (NCT04832776) | Fudan University | 2021-04-17 |
| Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC (NCT04855331) | Fudan University | 2021-04-15 |
| mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases (NCT04781270) | Fudan University | 2021-04-15 |
| Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study (NCT04831528) | Fudan University | 2021-04-10 |
| Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma (NCT04995120) | Fudan University | 2021-04-07 |
| Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma (NCT05420597) | Fudan University | 2021-04-07 |
| Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer (NCT05086614) | Fudan University | 2021-04-01 |
| A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) (NCT04734262) | Fudan University | 2021-04-01 |
| Study on Pulmonary Rehabilitation for Stable Chronic Obstructive Pulmonary Disease(COPD) Patients (NCT04741373) | Fudan University | 2021-04-01 |
| Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy. (NCT04835064) | Fudan University | 2021-04-01 |
| Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer (NCT05095636) | Fudan University | 2021-03-17 |
| Gene Abnormalities and Prognosis in Diffuse Large B-cell Lymphoma (NCT04825899) | Fudan University | 2021-03-08 |
| Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites (NCT04771676) | Fudan University | 2021-03-05 |
| The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer (NCT04535024) | Fudan University | 2021-03-04 |
| SRT for Residual Oligometastases of NSCLC After 3rd Generation EGFR-TKIs (NCT04764214) | Fudan University | 2021-03-01 |
| Neoadjuvant Radiation in Locally Advanced Breast Cancer (NCT05479409) | Fudan University | 2021-03-01 |
| NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors (NCT05131763) | Fudan University | 2021-03-01 |
| A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC) (NCT06749015) | Fudan University | 2021-03-01 |
| Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus Chemotherapy (NCT04707118) | Fudan University | 2021-02-23 |
| Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment (NCT04769050) | Fudan University | 2021-02-18 |
| PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-I (NCT04903665) | Fudan University | 2021-02-11 |
| Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer (NCT04745975) | Fudan University | 2021-02-01 |
| Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC (NCT04867330) | Fudan University | 2021-02-01 |
| Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases (NCT04687631) | Fudan University | 2021-01-14 |
| Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperplasia (NCT04607252) | Fudan University | 2021-01-11 |
| Tislelizumab Combined With Sitravatinib as Consolidation Treatment Following Concurrent Chemoradiation in Patients With Locally Advanced, Unresectable NSCLC (NCT05176925) | Fudan University | 2021-01-10 |
| Effect of a Probiotic Strain Lactobacillus Paracasei K56 on Metabolic Symptom - a Pilot Study (NCT04980599) | Fudan University | 2021-01-10 |
| Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma：FDZL-GC001 Trial (NCT04510064) | Fudan University | 2021-01-06 |
| Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer (NCT04947280) | Fudan University | 2021-01-01 |
| The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients (NCT05032768) | Fudan University | 2021-01-01 |
| Clinical Phenotype and Omics Study of KCNQ2-related Epilepsy (NCT05157737) | Fudan University | 2021-01-01 |
| IASLC Grading System as a Predictor for EGFR-TKI Therapy (NCT06131645) | Fudan University | 2021-01-01 |
| Dosimetric Limitation of Pelvic Bone and Peritoneal Space in Rectal Cancer Patients During Chemoradiotherapy (NCT05688033) | Fudan University | 2021-01-01 |